Brief: Merck To Acquire Verona Pharma for $10 billion
09/07/2025 11:33
July 9 (Reuters) - Verona Pharma PLC I9SAy.F: MERCK TO ACQUIRE VERONA PHARMA, EXPANDING ITS PORTFOLIO TO INCLUDE OHTUVAYRE® (ENSIFENTRINE), A FIRST-IN-CLASS COPD MAINTENANCE TREATMENT FOR ADULTS AND EXPECTED TO DRIVE GROWTH INTO THE NEXT DECADE VERONA PHARMA PLC - MERCK TO BUY VERONA PHARMA FOR $10 BILLION VERONA PHARMA PLC - MERCK TO PAY $107 PER ADS IN VERONA PHARMA DEAL VERONA PHARMA PLC - DEAL EXPECTED TO CLOSE IN Q4 2025 VERONA PHARMA PLC - MERCK AND VERONA PHARMA BOARDS APPROVE DEAL Source text: ID:nBw4v4tPha Further company coverage: [I9SAy.F] ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Verona Pharma
See all newsBrief: Acquisition Of Verona By Msd Approved By The High Court Of Justice Of England And Wales
Brief: Shareholders Of Verona Pharma Approve Proposed Acquisition By Merck
US corporate debt market returns in force after market holiday
Merck to cut jobs and costs as demand for Gardasil in China remains weak (updated)
Merck to cut jobs and costs as demand for Gardasil in China remains weak